D Crook

No ORCID on file · 6 papers in corpus · active 1992-2008

Study types

  • article 4
  • rct 2

Condition tags

  • endometriosis 6
  • dysmenorrhea 1
  • dyspareunia 1
article 2008
Zoladex versus Danazol in the Treatment of Pelvic Endometriosis: Effects on Plasma Lipid Risk Factors
Hormone research ·doi:10.1159/000181334

Plasma lipid risk markers for coronary heart disease (CHD) are influenced by sex steroid concentrations. Therapies that alter sex hormone levels have the potential to affect CHD risk. Zoladex had no effect on plasma lipids, but increased hi…

article 1997
Elevated serum lipoprotein(a) levels in young women with endometriosis
Metabolism: clinical and experimental ·doi:10.1016/s0026-0495(97)90115-3
rct 1995
Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial
Fertility and Sterility ·doi:10.1016/s0015-0282(16)57779-6

OBJECTIVE: To determine whether treatment of endometriosis with a GnRH analogue (GnRH-a; goserelin) combined with continuous estrogen and progestogen hormone replacement therapy (HRT) would prevent the hypoestrogenic effects, including loss…

rct 1993
A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(16)55793-8

OBJECTIVE: To study some of the metabolic effects of oral gestrinone on plasma lipoprotein risk markers for cardiovascular disease and on bone density, a risk marker for osteoporosis. DESIGN: Randomized double-blind study. SETTING: All pa…

article 1992
Danazol induces resistance to both insulin and glucagon in young women
Clinical science (London, England : 1979) ·doi:10.1042/cs0820211

1. Danazol elevates plasma insulin, plasma glucagon and serum low-density lipoprotein concentrations and reduces the serum high-density lipoprotein concentration. 2. Associations between these disturbances were studied in 17 women receiving…

article 1992
Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid
Atherosclerosis ·doi:10.1016/0021-9150(92)90008-5